INTRODUCTION
Heterotrimeric G protein signaling pathways are frequent targets for pharmacologic manipulation (Gilchrist, 2007) . The Ga subunit in its inactive, guanosine diphosphate (GDP)-bound conformation engages the obligate Gbg dimer (Oldham and Hamm, 2008) . A ligand-activated seven-transmembrane G proteincoupled receptor promotes nucleotide exchange on the Ga subunit. Upon binding of guanosine triphosphate (GTP) by the Ga subunit, three switch regions undergo a conformational change, leading to separation from Gbg and subsequent activation of downstream effectors, such as adenylyl cyclases, phospholipase C, and Rho-family guanine nucleotide exchange factors (RhoGEFs) (Aittaleb et al., 2010; Oldham and Hamm, 2008) . Signaling is terminated by the guanosine triphosphatase (GTPase) activity of the Ga subunit and reassembly of the Ga$GDP/Gbg heterotrimer.
''Regulator of G protein signaling'' (RGS) proteins accelerate the intrinsic GTP hydrolysis activity of Ga subunits and thereby serve as negative regulators of signaling (Kimple et al., 2011) . Canonical nine-helix RGS domains exhibit highest affinity for Ga in its transition-state mimetic form, stabilizing the switch regions for efficient hydrolysis (Tesmer et al., 1997) . Members of the RGS-RhoGEF family of Ga effectors contain N-termini with similarity to RGS domains (called ''RhoGEF-RGS'' or ''rgRGS'' domains) , in combination with Dbl homology (DH) and pleckstrin homology (PH) domains that together mediate activation of Rho family GTPases (Aittaleb et al., 2010) . The DH domain engages substrate Rho GTPases, promoting nucleotide release, while the PH domain frequently modulates exchange in various Dbl-family RhoGEF members (Rossman and Sondek, 2005) . In contrast to nine-helix RGS domains, rgRGS domains have a distinct 12-helix fold and engage Ga 12/13 subunits through an effector-like interface involving primarily switch 2 and the a3 helix (Aittaleb et al., 2010) . An N-terminal extension of the rgRGS domain containing an ''IIG'' sequence motif contacts the Ga 12/13 switch regions and all-helical domain and, in the case of p115 RhoGEF, is required for GTPase accelerating protein (GAP) activity toward Ga 12/13 subunits. Although structures of RGS-RhoGEFs with both the rgRGS and DH-PH domain tandems have not yet been elucidated, p115 RhoGEF is thought to be activated by an allosteric ''GEF switch'' mechanism that involves a conformational change of an N-terminal extension of the DH domain (Chen et al., 2011) . Recent low-resolution structural studies of full-length p115 RhoGEF suggest an elongated domain architecture and a potential bimodal interaction with Ga13, namely the effector interface with the rgRGS domain and a potential additional interface with the DH domain (Chen et al., 2012) . The activation mechanism of another mammalian RGS-RhoGEF, PDZ-RhoGEF, is thought to be complex, involving disruption of an electrostatic RGS-DH linker and DH domain interaction, perturbation of a putative RGS-DH linker ''molten globule,'' and membrane recruitment, as well as a ''GEF switch'' (Bielnicki et al., 2011; Zheng et al., 2009 ). Lowresolution small-angle X-ray scattering (SAXS) studies of PDZ-RhoGEF also suggested an ensemble of elongated domain architectures (Bielnicki et al., 2011) .
Entamoeba histolytica causes an estimated 50 million infections and 100,000 deaths per year worldwide, with highest incidence in countries with poor barriers between drinking water and sewage (WHO, 1997) . Following ingestion of encysted E. histolytica, the trophozoite or amoeboid form of the parasite attaches to and destroys intestinal epithelial cells, giving rise to amoebic colitis (Ralston and Petri, 2011) . Although the molecular details of signaling pathways in E. histolytica remain understudied, a relatively large family of Rho GTPases and Dbl family RhoGEFs are known to modulate cytoskeletal dynamics, as well as key pathogenic processes, such as trophozoite migration, extracellular matrix invasion, and killing and phagocytosis of host cells (Bosch et al., 2011a; Guillé n, 1996; Meza et al., 2006) .
Recently, we identified a functional heterotrimeric G protein signaling pathway in E. histolytica; perturbation of the Ga subunit, EhGa1, elucidated positive regulatory roles for G protein signaling in pathogenic processes, such as trophozoite migration and invasion, host cell attachment, and cell killing (Bosch et al., 2012) . Overexpression of either wild-type EhGa1 or a dominant negative mutant in E. histolytica trophozoites resulted in altered transcription of numerous genes that have implicated multiple potential mechanisms by which G protein signaling modulates pathogenesis. From this study, a set of Rho GTPase signaling proteins, including an RGS-RhoGEF, and actin-associated proteins was observed to be differentially transcribed downstream of heterotrimeric G-proteins (Table S1 available online). We hypothesized that EhRGS-RhoGEF, like its mammalian homologs, serves as an EhGa1 effector and signals through Rho family GTPases, with important roles in Entamoeba histolytica pathogenesis. Here our results describe EhRGS-RhoGEF as an effector and GAP of EhGa1, with importance for E. histolytica motility, host cell attachment, cell killing, and cysteine protease secretion. Activation of EhRGS-RhoGEF by coexpression of constitutively active EhGa1 and EhRacC leads to Rac family GTPase-dependent cell spreading in Drosophila S2 cells. Furthermore, we provide a crystal structure of the full-length RGS-RhoGEF in the inactive state, elucidating its molecular architecture and likely distinct evolutionary origin relative to the mammalian RGS-RhoGEFs.
RESULTS

EhGa1 Engages an RGS-RhoGEF Effector and GTPase Accelerating Protein
The E. histolytica genome encodes a single classical Ga subunit effector, an RGS domain-containing RhoGEF (GenBank XP_653063; named EhRGS-RhoGEF) with distant similarity to the RGS-RhoGEF effectors of mammalian Ga 12/13 subunits (Figure S1) . Transcription of EhRGS-RhoGEF was seen to be upregulated upon overexpression of EhGa1 in E. histolytica trophozoites, suggesting a functional link to heterotrimeric G protein signaling (Table S1 ). EhRGS-RhoGEF was purified from E. coli ( Figure S2 ) and found to bind directly to EhGa1 selectively in its GDP$AlF 4 À (AMF) nucleotide state, as measured by surface plasmon resonance ( Figures 1A-1D ). Reciprocal immobilization experiments each indicated an $5 mM EhGa1$AMF/EhRGS-RhoGEF dissociation constant (K D ). EhRGS-RhoGEF also interacted with the constitutively active, GTPase-deficient EhGa1 (Q189L) mutant in its GTP-bound form, although with $20-fold lower affinity than for EhGa1$AMF (K D z 110 mM) ( Figure 1B ). The EhGa1(Q189L)$GTP/EhRGS-RhoGEF binding affinity could not be precisely determined by equilibrium binding analysis, due to concentration limitations of our assay. The preference of EhRGS-RhoGEF for the AMF nucleotide state over the GTPbound state of EhGa1 is consistent with a similar order-ofmagnitude difference in p115 RhoGEF affinity for Ga i1/13 $AMF compared to Ga i1/13 $GTPgS (Chen et al., 2005) . To determine whether the interaction occurs through the RGS domain of EhRGS-RhoGEF, a conserved glutamate at the predicted Ga subunit-binding surface was mutated to lysine (E39K; Figure S1 ). Despite proper global folding of the E39K mutant ( Figure S2B ), it exhibited drastically reduced affinity for EhGa1$AMF ( Figure 1D ). The isolated RGS domain of EhRGS-RhoGEF could not be produced from E. coli. However, the RGS domain expressed in HEK293T cells was seen to specifically coprecipitate with purified EhGa1$AMF and EhGa1(Q189L)$GTP, but not EhGa1$GDP ( Figure S2C ), suggesting that the RGS domain alone is sufficient to bind EhGa1. The relatively high affinity of wild-type EhRGS-RhoGEF for the hydrolysis transition state-mimetic (AMF) form of EhGa1 suggested that the RGS domain of EhRGS-RhoGEF may serve as a GAP for EhGa1. Interestingly, EhRGS-RhoGEF lacks the N-terminal extension containing the IIG motif that is required for the GAP activity of p115 RhoGEF ( Figure S1 ; Aittaleb et al., 2010) . However, single turnover GTP hydrolysis assays demonstrated that wild-type EhRGS-RhoGEF, but not the EhRGS-RhoGEF(E39K) mutant, accelerates the intrinsic GTP hydrolysis activity of EhGa1 in a concentration-dependent fashion (Figure 1E) . Mutation of the conserved Asn-83 in the EhRGS-RhoGEF RGS domain, predicted to contact and orient EhGa1 switch residues for efficient catalysis of GTP hydrolysis (Tesmer et al., 1997) , also eliminated GAP activity ( Figure 1F ) and dramatically reduced EhRGS-RhoGEF/EhGa1 binding affinity ( Figure 1C ).
EhGa1 and EhRacC Activate EhRGS-RhoGEF to Promote Rho-Dependent Cell Spreading
To determine the ability of EhRGS-RhoGEF to modulate Rhodependent cellular processes and its potential regulation by EhGa1, we utilized Drosophila S2 cells that undergo a dramatic morphological transition with distinctive reorganization of actin structures when Rho family GTPases are activated by various stimuli (Rogers et al., 2003) . For example, overexpression of a GTPase-deficient and constitutively active D.m. Rac1(G14V) leads to cell spreading in $80% of S2 cells on a polylysine coated surface, as compared to $20% of cells expressing red fluorescent protein (Figures 2A and 2B ). Expression of constitutively active EhGa1(Q189L) and EhRGS-RhoGEF was not sufficient to significantly increase cell spreading. However, additional expression of constitutively active EhRacC(Q65L) lead to spreading, suggesting that GTP-bound EhGa1 and EhRacC are necessary to activate EhRGS-RhoGEF. Importantly, EhRacC(Q65L) alone (not shown) or in combination with EhGa1 ( Figure 2 ) did not trigger S2 cell spreading, indicating its inability to productively engage the endogenous D.m. Rho GTPase signaling machinery independently of EhRGS-RhoGEF. Wild-type EhGa1 did not activate EhRGS-RhoGEF, and the EhRGS-RhoGEF(E39K) mutation prevented an increase in cell spreading (Figures 2A and 2B) . Thus, coexpression of EhRGS-RhoGEF with constitutively active EhRacC and interaction with constitutively active EhGa1 at the RGS domain are required for enhanced cell spreading.
The observed cell-spreading phenotype strongly suggested that EhRGS-RhoGEF was signaling through endogenous Drosophila Rho family GTPases. To investigate the dependence of the observed phenotype on endogenous Rho family GTPases, we knocked down expression of D.m. Rac1/2 (both isoforms targeted), Rho, and mtl by RNA interference, as demonstrated previously in S2 cells (Rogers and Rogers, 2008) . Specific knock down of D.m. Rac GTPases abolished the cell-spreading effect of EhRGS-RhoGEF, EhGa1(Q189L), and EhRacC(Q65L), suggesting that either or both D.m. Rac isoforms may serve as substrates for overexpressed EhRGS-RhoGEF (Figure 2A) . [D] 5.7 ± 1.6 mM). The GTPase-deficient mutant EhGa1(Q189L) also interacted with EhRGS-RhoGEF, but with lower affinity (K D z 110 mM). Mutation of the conserved EhRGS-RhoGEF Asn-83, predicted to orient EhGa1 residues for rapid GTP hydrolysis, the predicted EhGa1-binding surface charge reversal EhRGS-RhoGEF(E39K), and the switch 1 mutant EhGa1(G168S) all drastically reduced binding affinity. Sensorgrams and equilibrium binding curves are representative of three experiments. (E and F) The GTPase rate of EhGa1 was accelerated by EhRGS-RhoGEF in a dose-dependent fashion (k obs = 0.20 ± 0.02 min À1 for EhGa1 alone and 1.45 ± 0.13 min À1 upon addition of 25 mM EhRGS-RhoGEF). EhRGS-RhoGEF(E39K) and EhRGS-RhoGEF(N83A) had no effect on the hydrolysis rate. (G) GTP hydrolysis rates for the ''RGS-insensitivity'' mutant EhGa1(G168S) alone or in the presence of a high concentration of EhRGS-RhoGEF were indistinguishable. Error bars represent standard error of the mean for duplicate reactions. Each single turnover hydrolysis experiment was independently repeated at least twice. Figure S2 indicates proper folding of the EhRGS-RhoGEF(E39K) mutant and nucleotide state-specific binding of EhGa1 to the isolated RGS domain.
Structure
EhRGS-RhoGEF Acts to Control Amoebic Pathogenesis
To test whether activated EhRacC directly engages EhRGS-RhoGEF, surface plasmon resonance was utilized. EhRGS-RhoGEF selectively bound EhRacC(Q65L)$GTP, to the exclusion of EhRacC$GDP or nucleotide-free EhRacC ( Figure 4D ). This pattern of nucleotide state selectivity was consistent with a Rho GTPase and effector-like interaction, rather than a RhoGEF and substrate Rho GTPase relationship. Although the observed recombinant EhRacC(Q65L)/EhRGS-RhoGEF affinity was relatively low (K D z 34 ± 9 mM), the cell-spreading experiments suggest that a productive interaction occurs in a cellular context. The interaction of EhRGS-RhoGEF with an active species of Rho family GTPase was reminiscent of the structurally elucidated interaction between human RhoA$GTPgS and a hydrophobic patch on the PH domain of PDZ-RhoGEF (Chen et al., 2010b ). An analysis of the PDZ-RhoGEF PH domain residues involved in activated RhoA binding (Protein Data Bank [PDB] 3KZ1) re-vealed poor conservation with the corresponding PH domain residues of EhRGS-RhoGEF (19% identity, 25% similarity); thus, we do not predict that EhRacC$GTP binds EhRGS-RhoGEF in a similar fashion. However, a direct interaction does occur between activated EhRacC and EhRGS-RhoGEF, potentially explaining the required coexpression of EhRacC(Q65L), together with EhGa1(Q189L) and EhRGS-RhoGEF to enhance cell spreading (Figures 2A and 2B ).
EhRGS-RhoGEF Modulates Pathogenic Processes of E. histolytica Trophozoites
We next investigated the role(s) of RGS-RhoGEF signaling in E. histolytica trophozoites by engineering the virulent HM-1:IMSS strain to stably overexpress wild-type EhRGS-RhoGEF ( Figure 3 ). We focused on measuring the effect of EhRGS-RhoGEF overexpression on trophozoite chemotactic migration, (Rogers and Rogers, 2008) . Coexpression of EhRGS-RhoGEF with GTPase-deficient and constitutively active EhGa1(Q189L) was insufficient to effect cell spreading. However, expression of the constitutively active EhRacC(Q65L) together with EhGa1(Q189L) and EhRGS-RhoGEF significantly enhanced cell spreading, while EhRacC(Q65L) alone or in combination with EhGa1 had no effect. To determine which D. melanogaster Rho family GTPases were necessary for cell spreading, and thus potential substrates for overexpressed EhRGS-RhoGEF, double-stranded RNAi was employed as described previously (Rogers et al., 2003) . RNAi-mediated knockdown of D.m. Rac isoforms, but not Rho or mtl, prevented significant enhancement of cell spreading by coexpression of EhRGS-RhoGEF, EhRacC(Q65L), and EhGa1(Q189L). Error bars represent standard deviation for three independent experiments, and * indicates statistically significant difference (p < 0.05) by Student's t test. Example micrographs are shown in (B) and western blots confirming expression of all E. histolytica proteins and mutants are shown in (C). (D) Recombinant, activated EhRacC(Q65L)$GTP was seen to directly bind EhRGS-RhoGEF by surface plasmon resonance, while EhRacC$GDP and nucleotidefree EhRacC exhibited negligible binding up to 40 mM concentration. Figure S1 contains sequence alignments of EhRGS-RhoGEF and mammalian homologs.
Structure
EhRGS-RhoGEF Acts to Control Amoebic Pathogenesis host cell attachment, and cell killing, given the known dependence of these vital pathogenic processes on actin cytoskeletal dynamics, as well as Rho GTPases and Dbl family RhoGEFs (Guillé n, 1996; Meza et al., 2006) . Trophozoites ectopically overexpressing EhRGS-RhoGEF killed host cells less efficiently than the parent strain, as indicated by a membrane integrity assay ( Figure 3A) . A number of cytotoxic proteins are involved in host cell killing, including membrane-perforating amoebapores and cysteine proteases (Ralston and Petri, 2011) . Reduced secretion of active cysteine proteases, as measured by an azo-collagen assay ( Figure 3B ), may account in part for the impaired cell killing of the EhRGS-RhoGEF-expressing trophozoite strain. Direct attachment of E. histolytica trophozoites to host epithelial cells, primarily through a galactose-inhibitable lectin (Petri et al., 2002) , is also required for tissue destruction. Amoebae overexpressing EhRGS-RhoGEF showed reduced attachment to Chinese hamster ovary (CHO) cell monolayers compared to the parent strain ( Figure 3D ). E. histolytica trophozoites are also highly motile, a feature that is dependent on a dynamic actin cytoskeleton regulated by Rho family GTPase signaling (Meza et al., 2006) . Transwell migration experiments indicated that overexpression of EhRGS-RhoGEF also decreases trophozoite chemotactic migration toward serum, but not random migration ( Figure 3C ), suggesting that interfering with the EhGa1/EhRGS-RhoGEF signaling axis modulates the E. histolytica migratory response to serum factors.
A Crystal Structure of EhRGS-RhoGEF While isolated domains from mammalian RGS-RhoGEFs have been structurally characterized (Aittaleb et al., 2010), a highresolution structure of an RGS domain together with a DH-PH domain tandem has not been elucidated to date. We obtained a crystal structure of a nearly full-length EhRGS-RhoGEF protein (lacking only two residues from each terminus) to 2.3 Å by single wavelength anomalous dispersion (SAD) ( Table 1 ). The structural model exhibits an N-terminal, canonical nine-helix RGS domain, an oblong DH domain, and a C-terminal PH domain ( Figure 4A ). The RGS domain interacts with the DH domain surface opposite from the PH domain and the putative Rho GTPase binding site ( Figure 4 ). The linker between the RGS and DH domains wraps around the oblong helical bundle of the DH domain ( Figure 4A ), forming an additional helix (termed the ''inhibitory helix'').
The RGS domain of EhRGS-RhoGEF is involved in multiple crystal contacts ( Figure S5) ; specifically, the putative Ga-binding surfaces of neighboring EhRGS-RhoGEF molecules in the crystal lattice contact one another. Although crystal contacts may modestly affect the disposition of the RGS domain, the similarity of its conformation to mammalian RGS domains in both crystallographic and nuclear magnetic resonance studies (Figure 6B; Soundararajan et al., 2008) and significant burial of hydrophobic surface area ($850 Å 2 ) at the RGS-DH domain interface suggest that the crystal structure architecture accurately reflects that of EhRGS-RhoGEF in solution.
The PH domain exhibits a conserved overall fold despite weak sequence similarity (2.9 Å root-mean-square deviation [rmsd] compared to 324 equivalent residues of the Dbs PH domain with only 51% sequence similarity) ( Figure S3A ). An analysis of protein sequence motifs and comparison of the EhRGS-RhoGEF PH domain structure to other PH domains in complex with phospholipid head groups (Ferguson et al., 2000) revealed poor conservation of a potential phospholipidbinding site on EhRGS-RhoGEF. Thus, we do not hypothesize 
EhRGS-RhoGEF Acts to Control Amoebic Pathogenesis that the EhRGS-RhoGEF PH domain directly associates with phospholipids.
The EhRGS-RhoGEF DH domain is most similar to that of intersectin (Dali server Z-score 19.4; PDB 1KI1). Superposition of Intersectin/Cdc42 (Snyder et al., 2002) and EhRGS-RhoGEF highlights a number of DH domain structural differences (Figure 4B) . The a6 helix of EhRGS-RhoGEF, which is the longest of the Intersectin DH domain, is disrupted by a loop, giving rise to two helices at $90 relative orientations (termed a6a and a6b). The PH domain adopts a very different orientation relative to the DH domain in EhRGS-RhoGEF as compared to Intersectin ( Figure 4B ). The PH domain of RGS-RhoGEF directly obstructs the putative Rho binding site, similar to a number of mammalian RhoGEFs, e.g., Vav and Sos (Das et al., 2000) . The DH and PH domains of EhRGS-RhoGEF share a substantial interface ($1200 Å 2 buried surface area) that occurs predominantly through hydrophobic interactions between the a7 helix of the PH domain and the a3d, a4, a5, and a6b helices of the DH domain ( Figure S3B) . Particularly, the hydrophobic side chains of Phe-393 and Met-397 project into an approximately triangular concavity formed by helices a3d, a4, and a5 ( Figure S3B ). The nature of the DH/PH domain interface suggests that the structural relationship between the two domains observed in the crystal structure likely also exists in solution. However, additional (B) The inhibitory helix, DH, and PH domains are superimposed with the structure of Intersectin/Cdc42 (gray; PDB 1KI1). The conserved site of Rho GTPase interaction, illustrated by a surface rendering of Cdc42, is obstructed in the case of EhRGS-RhoGEF. The inhibitory helix lies entirely within the space corresponding to Cdc42. In addition, the long a6 helix is continuous in Intersectin and other RhoGEFs, but is segmented into two helices related by an $90 angle in EhRGS-RhoGEF. The a6b helix both interacts with the putative inhibitory helix and contributes to obstruction of the Rho binding site. The EhRGS-RhoGEF PH domain is also predicted to interfere with Rho binding in this inactive conformation. Figure S3 contains an analysis of the PH domain and its DH domain interface.
EhRGS-RhoGEF Acts to Control Amoebic Pathogenesis contacts of each domain with the inhibitory helix may also be necessary to maintain the observed DH and PH domain relationship ( Figure 5) , and alternative conformations are also possible.
The Inhibitory Helix Coordinates Occlusion of the Rho GTPase Binding Site
In the inactive state of EhRGS-RhoGEF, the inhibitory helix, the a6b helix of the DH domain, and the PH domain all obstruct the presumptive Rho GTPase interaction surface of the DH domain (Figure 4) , as predicted based on comparison with the Intersectin/Cdc42 structure (Snyder et al., 2002) . In fact, the entire RGS-DH domain linker inhibitory helix lies within the space occupied by the Rho GTPase substrate in numerous, well-conserved Dbl family GEF/Rho interactions (Rossman and Sondek, 2005) . The inhibitory helix interacts with both the DH and PH domains through a series of hydrophobic and polar interactions ( Figure 5 and S4) . The hydrophobic residues Leu-164, Ile-167, Ile-168, and Trp-175 interface with a hydrophobic patch at the DH a6B helix/PH domain interface, consisting primarily of the hydrophobic portion of Lys-386, Leu-387, Ile-406, and Ile-450 ( Figure 5 and S4 ). Surrounding the hydrophobic patch are a number of apparent polar and ionic interactions, including those between Lys-161 of the inhibitory helix and Glu-511 of the PH domain as well as Lys-172 and Asp-383 of the inhibitory and DH domain a6B helices, respectively. The inhibitory helix residues Lys-166 and Ile-170 also form limited contacts with a DH domain loop from a neighboring molecule in the crystal lattice ( Figure S5C ), but these contacts likely do not contribute to the observed main chain conformation. Notably, the RGS-DH linker containing the putative inhibitory helix is much shorter in EhRGS-RhoGEF (26 residues) than the corresponding linker in its mammalian homologs, with p115 RhoGEF possessing the next shortest linker at 164 residues ( Figure S1C ). Thus, it is likely that this region exhibits different structural features and potentially performs different functions in mammalian RGS-RhoGEFs.
Convergent Evolution of the EhGa1/EhRGS-RhoGEF Interface
The RGS/DH domain interface consists of a central hydrophobic region with peripheral hydrogen bond and ionic interactions (Figure 6A and S4B) . The residues corresponding to this domain interface are not highly conserved among mammalian RGS-RhoGEFs, such as p115 RhoGEF (Figure S1 ). This observation, together with a previous SAXS analysis of the elongated p115 RhoGEF (Chen et al., 2012) , suggests that the structural relationships among the EhRGS-RhoGEF domains differ from those of mammalian homologs.
The RGS domain of EhRGS-RhoGEF closely resembles the nine-helix bundle found in canonical RGS domains, such as RGS4 ( Figure 6B ). This canonical RGS domain fold is distinct from the 12-helix rgRGS domains of mammalian RGS-RhoGEFs, such as p115 ( Figure 6C ; Aittaleb et al., 2010) . EhRGS-RhoGEF is unique in possessing a canonical nine-helix RGS domain, suggesting that the RGS and DH-PH domain combination within E. histolytica may have arisen through an independent evolutionary mechanism.
In addition to possessing a distinctive RGS domain fold, the mammalian RGS-RhoGEFs engage Ga 12/13 subunits through an effector-like interface, primarily utilizing switch 2 and the a3 helix on Ga, although the N-terminal extension of the rgRGS domain required for GAP activity also contacts the three switches and the all-helical domain ( Figure 7B ; Aittaleb et al., 2010) . In contrast, canonical nine-helix RGS domains primarily interface with Ga switches 1 and 2 ( Figure 7A ; Soundararajan et al., 2008) ; hence, the Ga subunit switch 1 Gly-to-Ser ''RGS-insensitivity'' mutation selectively disrupts canonical RGS domain interactions, but not Ga/rgRGS domain interactions (Lan et al., 1998; Meigs et al., 2005) . To test whether the EhRGS-RhoGEF RGS domain interfaces with EhGa1 in a canonical fashion, we generated the EhGa1(G168S) mutant. EhRGS-RhoGEF exhibited drastically lower affinity for EhGa1(G168S) than wildtype EhGa1, as measured by surface plasmon resonance, and was unable to affect the intrinsic GTPase rate of EhGa1(G168S) (Figures 1B and 1G) . These experiments suggest that the EhGa1/EhRGS-RhoGEF interface most likely resembles a canonical RGS/Ga interaction, providing further evidence for an independent evolutionary mechanism giving rise to a Ga/ RGS-RhoGEF signaling axis in E. histolytica. Figure S4 .
DISCUSSION
The E. histolytica Ga subunit is divergent in its amino acid sequence as compared to mammalian Ga subunits and, in particular, does not belong to the Ga 12/13 subfamily that couples to mammalian RGS-RhoGEFs ( Figure S6 ). However, EhGa1 does engage the RGS domain of EhRGS-RhoGEF in a nucleotide state-dependent fashion, resulting in accelerated GTP hydrolysis. A search of publicly available sequenced genomes identified the RGS and DH-PH tandem domain combination exclusively in metazoan species (e.g., C. elegans and D. melanogaster) with the only nonmetazoan exception being the Entamoeba species. Resistance of EhGa1 to conventional Ga subfamily classification, the RGS4-like nine-helix RGS domain fold of the EhRGS-RhoGEF N terminus, and the canonical nature of the EhGa1/EhRGS-RhoGEF interface, as evidenced by the EhGa1(G168S), EhRGS-RhoGEF(N83A), and EhRGS-RhoGEF(E39K) mutants, all suggest an evolutionary origin independent of the Ga 12/13 /RGS-RhoGEF signaling axis present in mammals.
Mammalian RGS-RhoGEFs are thought to achieve full activation through integration of multiple signals, including, but not limited to, interactions with Ga 12/13 . For instance, Ga 12 -mediated stimulation of leukemia-associated RhoGEF requires tyrosine phosphorylation by Tec (Suzuki et al., 2003) . Consistent with this theme, EhRGS-RhoGEF requires coexpression, not only with constitutively active EhGa1, but also with constitutively active EhRacC, to achieve apparent activation, as evidenced by S2 cell spreading. Little is currently known about EhRacC signaling in E. histolytica, although it is evidently a substrate for EhGEF2 in vitro (Gonzá lez De la Rosa et al., 2007) . EhRacC was seen to bind EhRGS-RhoGEF directly, exclusively in the GTP-bound conformation, suggesting that EhRGS-RhoGEF Figure S4B.  (B) The EhRGS-RhoGEF RGS domain adopts a nine-helical bundle fold very similar to canonical RGS domains, typified by RGS4 (red; PDB 1AGR). (C) In contrast, the mammalian RGS-RhoGEFs possess an RGS-like domain with 12 helices, as seen in p115 RGS-RhoGEF (PDB 1IAP). Dotted lines indicate loops that could not be accurately modeled. Figure S5 illustrates crystal contacts of the RGS domain and inhibitory helix. may serve as an EhRacC effector. Activated human RhoA GTPase has been demonstrated to bind the PH domain of PDZ-RhoGEF in an analogous fashion (Chen et al., 2010b) . RhoA also serves as a substrate for PDZ-RhoGEF-mediated exchange, suggesting a possible mode of feedback regulation in mammals. However, there is currently no evidence that EhRacC is a substrate for EhRGS-RhoGEF; in fact, EDTAtreated, nucleotide-free EhRacC did not bind appreciably to EhRGS-RhoGEF ( Figure 2D ). However, the full-length, isolated EhRGS-RhoGEF used in these experiments is expected to have an obstructed Rho substrate-binding site, and activation by EhGa1$GTP, EhRacC$GTP, and/or other factors may be required to allow efficient substrate binding. Although the putative exchange factor activity of EhRGS-RhoGEF was not directly measureable, selective knockdown of endogenous D.m. Rac1/2 in S2 cells impaired the cell spreading triggered by coexpression of EhRGS-RhoGEF, EhGa1(Q/L), and EhRacC(Q/L), suggesting that Drosophila Rac may serve as a substrate for EhRGS-RhoGEF in a cellular context. However, the cell spreading experiments provide limited insight into the precise signaling mechanics. For instance, additional cellular factors may contribute to EhRGS-RhoGEF activation, and we cannot rule out the possibility that overexpressed E. histolytica signaling components promote cell spreading through other endogenous signaling pathways.
In isolation, EhRGS-RhoGEF appears to adopt an autoinhibited conformation, with direct obstruction of the presumptive Rho substrate-binding surface by a putative inhibitory helix and its DH and PH domain interactions. We hypothesize that binding of EhGa1$GTP and EhRacC$GTP to EhRGS-RhoGEF, possibly together with other cellular context factors, such as membrane localization or posttranslational modifications, may lead to a structural rearrangement of the putative inhibitory helix and the PH domain, allowing for substrate Rho GTPase binding and nucleotide exchange. The predicted mode of EhRGS-RhoGEF autoinhibition, as derived from the crystal structure, is comparable to that of mammalian PDZ-RhoGEF, seen in solution studies (Zheng et al., 2009) . However, in the case of PDZ-RhoGEF, an acidic stretch of its rgRGS-DH domain linker interacts with a DH domain surface basic cluster, distinct from the inhibitory helix interface seen here in the crystal structure of EhRGS-RhoGEF. The rgRGS-DH linker of p115 RhoGEF also apparently inhibits the GEF activity of its DH-PH domain tandem, although both SAXS analyses and crystallographic studies of the DH-PH domains with short segments of the linker intact suggest a different linker disposition than that seen in EhRGS-RhoGEF (Chen et al., 2011) . The RGS-DH linker in EhRGS-RhoGEF is >100 residues shorter than those of mammalian homologs ( Figure S1C ), further suggesting that this region does not have a conserved structure across species.
Endogenous EhRGS-RhoGEF likely represents a functional signaling link between heterotrimeric G-proteins and Rho family GTPases in E. histolytica. Indeed, Rho GTPases and other Dbl family RhoGEFs in E. histolytica are also known to regulate multiple processes important for pathogenesis, such as actin reorganization during chemotaxis, surface receptor capping, cell killing, phagocytosis, and tissue destruction (Guillé n, 1996) . A surprisingly large family of Rho GTPases (>20 members) is apparently simultaneously expressed in the single-celled parasite (Bosch et al., 2011a) . Further studies are needed to determine which Rho family members are activated by EhRGS-RhoGEF and what downstream signaling pathways are utilized.
Overexpression of EhRGS-RhoGEF resulted in reduced E. histolytica trophozoite chemotactic migration, attachment to and killing of host cells, and secretion of cysteine proteases. By each of these measures, the EhRGS-RhoGEF trophozoite strain phenocopies a strain overexpressing a dominant negative EhGa1 point mutant and exhibits an opposing trend to trophozoites overexpressing wild-type EhGa1 (Bosch et al., 2012) , consistent with ectopically overexpressed EhRGS-RhoGEF serving to accelerate GTP hydrolysis on EhGa1 and thus inhibit its signaling. Given the amenability of heterotrimeric G protein signaling to pharmacological manipulation (Gilchrist, 2007) , this pathway provides a promising drug target for the treatment of amoebic colitis.
EXPERIMENTAL PROCEDURES
Cloning and Protein Purification See Supplemental Experimental Procedures.
Crystallization and Structure Determination
Crystals of the full-length EhRGS-RhoGEF (aa 1-519) yielded diffraction data not suitable for either molecular replacement or anomalous dispersion. However, by removing two residues on both the N-and C-termini of EhRGS-RhoGEF, we obtained another crystal form with improved diffraction quality, ultimately allowing structure determination by SAD. Crystallization was achieved by hanging drop vapor diffusion at 18 C. EhRGS-RhoGEF at 15 mg/ml in crystallization buffer (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES] pH 7.5, 100 mM NaCl, and 1 mM dithiothreitol) was mixed 1:1 and equilibrated against crystallization solution containing 16% (w/v) polyethylene glycol 3350 and 100 mM sodium malonate pH 5.0. Hexagonal plate crystals grew to 400 3 150 3 20 mm over 5 days. EhRGS-RhoGEF crystals displayed the symmetry of space group C2 (a = 86.1 Å , b = 46.3 Å , c = 142.6 Å , a = g = 90 , b = 104.2 ), with one monomer in the asymmetric unit. Prior to data collection, crystals were cryoprotected in crystallization solution supplemented with 25% (v/v) glycerol.
Figure 7. Evolutionary Analysis of the EhGa1/EhRGS-RhoGEF Signaling Pathway
Canonical RGS domains, illustrated by RGS4 (PDB 1AGR), and rgRGS domains of mammalian RGS-RhoGEFs, represented by that of p115 (PDB 3AB3), exhibit distinct folds. (A) The EhRGS-RhoGEF RGS domain structure (yellow) closely resembles RGS4 (red), suggesting a canonical Ga/RGS domain interaction as exhibited by the RGS4/Ga i1 complex. Canonical RGS domains engage primarily switches 1 and 2, while rgRGS domains interact with the effector interface of Ga 12/13 (orange) family members, primarily through switch 2 and the a3 helix, although the N-terminal extension required for GAP activity also contacts the three switch regions and the all-helical domain (B). The EhGa1(G168S), EhRGS-RhoGEF(E39K), and EhRGS-RhoGEF(N83A) mutations can distinguish between the two modes of binding by selectively disrupting the canonical RGS domain binding site. Divergence of EhGa1 sequence from known mammalian subfamilies, together with the canonical nine-helix RGS domain of EhRGS-RhoGEF and its mode of EhGa1 interaction, suggest that the EhGa1/RGS-RhoGEF signaling axis arose by an evolutionary mechanism distinct from and functionally convergent with that of the mammalian Ga 12/13 /RGS-RhoGEF axis. Figure S6 contains a comparison of EhGa1 to mammalian Ga subfamily members.
Structure
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Anomalous diffraction data were obtained at 0.97954 Å wavelength (selenium absorption peak) and 100 K temperature at the GM/CA-CAT ID-D beamline (APS, Argonne National Labs) and processed using HKL2000 (Otwinowski and Minor, 1997) . A highly redundant data set was obtained combining partial data sets from five points along the EhRGS-RhoGEF plate crystal. Heavy atom searching identified eight of eight possible sites, and refinement yielded an estimated Bayes correlation coefficient of 48.2 to 2.5 Å resolution. After density modification, the estimated Bayes correlation coefficient increased to 66.0. Approximately 75% of the model was constructed automatically, and the remaining portion was built manually. The current model (Table 1) contains one EhRGS-RhoGEF monomer.
Refinement was carried out against peak anomalous data with Bijvoet pairs kept separate using phenix.refine (Adams et al., 2010) interspersed with manual model revisions using the program Coot (Emsley and Cowtan, 2004) and consisted of conjugate-gradient minimization and calculation of individual atomic displacement and translation/libration/screw parameters (Painter and Merritt, 2006) . Residues that could not be identified in the electron density were: 1, 139, 140, 153-156, and 452-454 . The model exhibits excellent geometry, as determined by MolProbity (Chen et al., 2010a) . A Ramachandran analysis identified 97.6% favored, 2.4% allowed, and 0% disallowed residues. Coordinates and structure factors are deposited in the RCSB Protein Data Bank (4GOU).
Single Turnover Nucleotide Hydrolysis GTP hydrolysis by single turnover assays was quantified as previously described (Bosch et al., 2011b) . For GTPase acceleration assays, increasing concentrations of purified EhRGS-RhoGEF were added along with the hydrolysis-initiating magnesium.
Surface Plasmon Resonance
Optical detection of protein binding was conducted as described previously . Briefly, His 6 -tagged wild-type or mutant EhRGS-RhoGEF was immobilized on an nitrilotriacetic acid (NTA) chip surface by capture coupling and increasing concentrations of wild-type EhGa1, and mutants were flowed over at 10 ml/s in various nucleotide states. In complementary experiments, glutathione S-transferase (GST)-EhGa1 was immobilized on an anti-GST chip surface, as described (Hutsell et al., 2010) , and increasing concentrations of EhRGS-RhoGEF and mutants flowed over. 
NTA Affinity Coprecipitation
Chemotactic Migration
Trophozoite migration assays were performed essentially as described previously (Gilchrist et al., 2008) . Briefly, amoebae harvested in log growth phase were suspended in serum-free trypticase yeast extract iron growth medium and 50,000 cells loaded in the upper chamber of a Transwell migration chamber (Costar, 8 mm pore size). The lower chamber contained growth medium with or without 15% adult bovine serum. Transwell plates were incubated at 37 C for 2 hr under anaerobic conditions (GasPak EZ, BD Biosciences).
Host Cell Attachment
Attachment of E. histolytica trophozoites to epithelial monolayers was assessed as previously described (Shrimal et al., 2010) . CHO cells were grown to confluency in 24 well plates, washed, and fixed in 4% paraformaldehyde for 30 min. Trophozoites (3 3 10 5 ) were added to the fixed monolayers in medium 199 supplemented with 5.7 mM cysteine, 1 mM ascorbic acid, and 25 mM HEPES (pH 6.9). After incubation at 37 C for 30 min, each well was washed gently two times with warm PBS to remove unattached trophozoites. Monolayer-attached trophozoites were quantified by counting with an inverted microscope. Each experiment was performed in quadruplicate and statistical significance determined by Student's t test.
Cell Killing
Killing of mammalian cells (Jurkat) was assessed using the CytoTox-ONE membrane integrity assay (Promega). In 96-well plates, 5 3 10 5 Jurkat cells and/or 2.5 3 10 5 trophozoites were incubated at 37 C in 200 ml of medium 199 (Sigma) supplemented with 5.7 mM cysteine, 0.5% BSA, and 25 mM HEPES pH 6.8. After 2 hr, 50 ml of medium from each well was incubated with Cytotox reagent, and a colorimetric measure of extracellular lactate dehydrogenase activity was obtained after 10 min. Each experiment was performed in quadruplicate and statistical significance determined by Student's t test.
Cysteine Protease Activity See Supplemental Experimental Procedures.
S2 Cell Culture and Spreading Assay S2 cells were obtained from the Drosophila Genome Resource Center (Bloomington, IL), and cultivated as described previously (Rogers and Rogers, 2008) . S2 cells were maintained in SF900 SFM (Invitrogen, Carlsbad, CA) and transfected with 2 mg total DNA using the Amaxa nucleofector system (Lonza, Basel, Switzerland). Expression of transfected constructs was induced with 35 mM CuSO 4 . Double-stranded RNAs (see Supplemental Experiment Procedures for primers) were produced using a Promega (Madison, WI) Ribomax T7 kit according to manufacturer instructions. S2 cells at 50%-90% confluency in six-well plates were treated every other day for 7 days with 7.5 mg/ml of double-stranded RNA. On day 5 of RNA interference (RNAi) treatment, cells were transfected as above and then induced on day 6. Cells were resuspended and plated on poly-L-lysine (Sigma-Aldrich, St. Louis, MO)-coated coverslips and allowed to spread for 1 hr. For quantifying numbers of cells with spreading, each condition was repeated at least three times and R100 cells were counted per experiment. 
Immunofluorescence Microscopy
